Selected research
Industry Research
Acute Sinusitis Industry Research Report 2026
Market perspective
The global Acute Sinusitis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Acute Sinusitis market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Acute Sinusitis market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Acute Sinusitis market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Acute Sinusitis include Bionorica, Bristol-Myers Squibb, Dr. Reddy's Laboratories, AstraZeneca, Amgen, Bayer, Fresenius Kabi, Pfizer and Eli Lilly and Company, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Acute Sinusitis market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Acute Sinusitis.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Acute Sinusitis Market by Company
Bionorica
Bristol-Myers Squibb
Dr. Reddy's Laboratories
AstraZeneca
Amgen
Bayer
Fresenius Kabi
Pfizer
Eli Lilly and Company
Merck
Novartis
Johnson & Johnson
Sanofi
Sun Pharmaceutical
Teva Pharmaceutical
Abbott
Acute Sinusitis Segment by Type
Saline Nasal Spray
Nasal Corticosteroids
OTC Pain Relievers
Others
Acute Sinusitis Segment by Application
Hospital
Clinic
Acute Sinusitis Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acute Sinusitis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acute Sinusitis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acute Sinusitis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Acute Sinusitis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Saline Nasal Spray
- Nasal Corticosteroids
- OTC Pain Relievers
- Others
Applications
- Hospital
- Clinic
Companies covered
- Bionorica
- Bristol-Myers Squibb
- Dr. Reddy's Laboratories
- AstraZeneca
- Amgen
- Bayer
- Fresenius Kabi
- Pfizer
- Eli Lilly and Company
- Merck
- Novartis
- Johnson & Johnson
- Sanofi
- Sun Pharmaceutical
- Teva Pharmaceutical
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Acute Sinusitis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Saline Nasal Spray
- 2.2.3 Nasal Corticosteroids
- 2.2.4 OTC Pain Relievers
- 2.2.5 Others
- 2.3 Acute Sinusitis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.4 Assumptions and Limitations
3 Acute Sinusitis Breakdown Data by Type
- 3.1 Global Acute Sinusitis Historic Market Size by Type (2021-2026)
- 3.2 Global Acute Sinusitis Forecasted Market Size by Type (2027-2032)
4 Acute Sinusitis Breakdown Data by Application
- 4.1 Global Acute Sinusitis Historic Market Size by Application (2021-2026)
- 4.2 Global Acute Sinusitis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Acute Sinusitis Market Perspective (2021-2032)
- 5.2 Global Acute Sinusitis Growth Trends by Region
- 5.2.1 Global Acute Sinusitis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Acute Sinusitis Historic Market Size by Region (2021-2026)
- 5.2.3 Acute Sinusitis Forecasted Market Size by Region (2027-2032)
- 5.3 Acute Sinusitis Market Dynamics
- 5.3.1 Acute Sinusitis Industry Trends
- 5.3.2 Acute Sinusitis Market Drivers
- 5.3.3 Acute Sinusitis Market Challenges
- 5.3.4 Acute Sinusitis Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Acute Sinusitis Players by Revenue
- 6.1.1 Global Top Acute Sinusitis Players by Revenue (2021-2026)
- 6.1.2 Global Acute Sinusitis Revenue Market Share by Players (2021-2026)
- 6.2 Global Acute Sinusitis Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Acute Sinusitis Head Office and Area Served
- 6.4 Global Acute Sinusitis Players, Product Type & Application
- 6.5 Global Acute Sinusitis Manufacturers Established Date
- 6.6 Global Acute Sinusitis Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Acute Sinusitis Market Size (2021-2032)
- 7.2 North America Acute Sinusitis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Acute Sinusitis Market Size by Country (2021-2026)
- 7.4 North America Acute Sinusitis Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Acute Sinusitis Market Size (2021-2032)
- 8.2 Europe Acute Sinusitis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Acute Sinusitis Market Size by Country (2021-2026)
- 8.4 Europe Acute Sinusitis Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Acute Sinusitis Market Size (2021-2032)
- 9.2 Asia-Pacific Acute Sinusitis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Acute Sinusitis Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Acute Sinusitis Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Acute Sinusitis Market Size (2021-2032)
- 10.2 South America Acute Sinusitis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Acute Sinusitis Market Size by Country (2021-2026)
- 10.4 South America Acute Sinusitis Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Acute Sinusitis Market Size (2021-2032)
- 11.2 Middle East & Africa Acute Sinusitis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Acute Sinusitis Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Acute Sinusitis Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Bionorica
- 12.1.1 Bionorica Company Information
- 12.1.2 Bionorica Business Overview
- 12.1.3 Bionorica Revenue in Acute Sinusitis Business (2021-2026)
- 12.1.4 Bionorica Acute Sinusitis Product Portfolio
- 12.1.5 Bionorica Recent Developments
- 12.2 Bristol-Myers Squibb
- 12.2.1 Bristol-Myers Squibb Company Information
- 12.2.2 Bristol-Myers Squibb Business Overview
- 12.2.3 Bristol-Myers Squibb Revenue in Acute Sinusitis Business (2021-2026)
- 12.2.4 Bristol-Myers Squibb Acute Sinusitis Product Portfolio
- 12.2.5 Bristol-Myers Squibb Recent Developments
- 12.3 Dr. Reddy's Laboratories
- 12.3.1 Dr. Reddy's Laboratories Company Information
- 12.3.2 Dr. Reddy's Laboratories Business Overview
- 12.3.3 Dr. Reddy's Laboratories Revenue in Acute Sinusitis Business (2021-2026)
- 12.3.4 Dr. Reddy's Laboratories Acute Sinusitis Product Portfolio
- 12.3.5 Dr. Reddy's Laboratories Recent Developments
- 12.4 AstraZeneca
- 12.4.1 AstraZeneca Company Information
- 12.4.2 AstraZeneca Business Overview
- 12.4.3 AstraZeneca Revenue in Acute Sinusitis Business (2021-2026)
- 12.4.4 AstraZeneca Acute Sinusitis Product Portfolio
- 12.4.5 AstraZeneca Recent Developments
- 12.5 Amgen
- 12.5.1 Amgen Company Information
- 12.5.2 Amgen Business Overview
- 12.5.3 Amgen Revenue in Acute Sinusitis Business (2021-2026)
- 12.5.4 Amgen Acute Sinusitis Product Portfolio
- 12.5.5 Amgen Recent Developments
- 12.6 Bayer
- 12.6.1 Bayer Company Information
- 12.6.2 Bayer Business Overview
- 12.6.3 Bayer Revenue in Acute Sinusitis Business (2021-2026)
- 12.6.4 Bayer Acute Sinusitis Product Portfolio
- 12.6.5 Bayer Recent Developments
- 12.7 Fresenius Kabi
- 12.7.1 Fresenius Kabi Company Information
- 12.7.2 Fresenius Kabi Business Overview
- 12.7.3 Fresenius Kabi Revenue in Acute Sinusitis Business (2021-2026)
- 12.7.4 Fresenius Kabi Acute Sinusitis Product Portfolio
- 12.7.5 Fresenius Kabi Recent Developments
- 12.8 Pfizer
- 12.8.1 Pfizer Company Information
- 12.8.2 Pfizer Business Overview
- 12.8.3 Pfizer Revenue in Acute Sinusitis Business (2021-2026)
- 12.8.4 Pfizer Acute Sinusitis Product Portfolio
- 12.8.5 Pfizer Recent Developments
- 12.9 Eli Lilly and Company
- 12.9.1 Eli Lilly and Company Company Information
- 12.9.2 Eli Lilly and Company Business Overview
- 12.9.3 Eli Lilly and Company Revenue in Acute Sinusitis Business (2021-2026)
- 12.9.4 Eli Lilly and Company Acute Sinusitis Product Portfolio
- 12.9.5 Eli Lilly and Company Recent Developments
- 12.10 Merck
- 12.10.1 Merck Company Information
- 12.10.2 Merck Business Overview
- 12.10.3 Merck Revenue in Acute Sinusitis Business (2021-2026)
- 12.10.4 Merck Acute Sinusitis Product Portfolio
- 12.10.5 Merck Recent Developments
- 12.11 Novartis
- 12.11.1 Novartis Company Information
- 12.11.2 Novartis Business Overview
- 12.11.3 Novartis Revenue in Acute Sinusitis Business (2021-2026)
- 12.11.4 Novartis Acute Sinusitis Product Portfolio
- 12.11.5 Novartis Recent Developments
- 12.12 Johnson & Johnson
- 12.12.1 Johnson & Johnson Company Information
- 12.12.2 Johnson & Johnson Business Overview
- 12.12.3 Johnson & Johnson Revenue in Acute Sinusitis Business (2021-2026)
- 12.12.4 Johnson & Johnson Acute Sinusitis Product Portfolio
- 12.12.5 Johnson & Johnson Recent Developments
- 12.13 Sanofi
- 12.13.1 Sanofi Company Information
- 12.13.2 Sanofi Business Overview
- 12.13.3 Sanofi Revenue in Acute Sinusitis Business (2021-2026)
- 12.13.4 Sanofi Acute Sinusitis Product Portfolio
- 12.13.5 Sanofi Recent Developments
- 12.14 Sun Pharmaceutical
- 12.14.1 Sun Pharmaceutical Company Information
- 12.14.2 Sun Pharmaceutical Business Overview
- 12.14.3 Sun Pharmaceutical Revenue in Acute Sinusitis Business (2021-2026)
- 12.14.4 Sun Pharmaceutical Acute Sinusitis Product Portfolio
- 12.14.5 Sun Pharmaceutical Recent Developments
- 12.15 Teva Pharmaceutical
- 12.15.1 Teva Pharmaceutical Company Information
- 12.15.2 Teva Pharmaceutical Business Overview
- 12.15.3 Teva Pharmaceutical Revenue in Acute Sinusitis Business (2021-2026)
- 12.15.4 Teva Pharmaceutical Acute Sinusitis Product Portfolio
- 12.15.5 Teva Pharmaceutical Recent Developments
- 12.16 Abbott
- 12.16.1 Abbott Company Information
- 12.16.2 Abbott Business Overview
- 12.16.3 Abbott Revenue in Acute Sinusitis Business (2021-2026)
- 12.16.4 Abbott Acute Sinusitis Product Portfolio
- 12.16.5 Abbott Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst